跳至主要内容
临床试验/NCT01069016
NCT01069016已完成不适用

Comparison of Sacral Nerve Modulation and Pudendal Nerve Stimulation in Treatment of Fecal Incontinence

Cantonal Hospital of St. Gallen1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2010年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Power consumption of stimulator

研究概览

简要总结

Sacral nerve modulation (SNM) is an established treatment for refractory lower urinary tract and bowel dysfunction (Spinelli 2008). Pudendal nerve stimulation (PNS) has been proposed for patients failing SNM treatment of urinary dysfunction (Spinelli 2005). In this study SNM and PNS are compared for the treatment of fecal incontinence. In a test phase, both treatments will be applied for one week each in a randomized and blinded order (cross-over design). After the test phase the more successful treatment will be determined and applied permanently. If both treatments are equally sufficient, PNS will be chosen for permanent stimulation, since preliminary data indicate that PNS has a lower power consumption than SNM. Lower power consumption results in a longer lifetime of the stimulator, thus requiring less replacement surgeries.

详细描述

Primary Surgery:

  • Implantation of two electrodes, one placed next to the sacral nerve, one close to the pudendal nerve. Electrode wires are passed through the skin just above the gluteal region and are marked S and P. One of the sub-investigators (not involved in the follow-up) replaces the S and P marks by 1 and 2 marks in absence of the operating surgeon. Assignment of 1 and 2 is carried out in a predefined randomized fashion (computerized block randomization).

Test phase:

  • Electrode labeled 1 is connected to a stimulator and the nerve is stimulated for one week, then the other electrode is stimulated for a week.
  • Based on bowel habit diary, Wexner score (Jorge 1993) and subjective experience of the patient, the more successful treatment is chosen. If both electrodes were equally successful, the pudendal nerve electrode will be chosen for permanent stimulation.

Secondary surgery:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •fecal incontinence nonresponsive to conservative treatment

排除标准

  • •sacral or perineal infection
  • •sphincter defect larger than 60° (sonography)
  • •pregnancy

研究组 & 干预措施

Sacral nerve modulation first

Experimental

Sacral nerve modulation is applied before the pudendal nerve stimulation. There is no "wash-out" period (pause) between the two treatments.

干预措施: Sacral nerve modulation (Procedure)

Sacral nerve modulation first

Experimental

Sacral nerve modulation is applied before the pudendal nerve stimulation. There is no "wash-out" period (pause) between the two treatments.

干预措施: Pudendal nerve stimulation (Procedure)

Pudendal nerve stimulation first

Experimental

Pudendal nerve stimulation is applied before the sacral nerve modulation. There is no "wash-out" period (pause) between the two treatments.

干预措施: Sacral nerve modulation (Procedure)

Pudendal nerve stimulation first

Experimental

Pudendal nerve stimulation is applied before the sacral nerve modulation. There is no "wash-out" period (pause) between the two treatments.

干预措施: Pudendal nerve stimulation (Procedure)

结局指标

主要结局

Power consumption of stimulator

时间窗: 14 days

次要结局

  • Wexner Score (Jorge 1993)(7, 14 days, 3, 6 & 12 months)
  • Quality of Life (FIQL (Rockwood 2000))(14 days, 3, 6 & 12 months)
  • Incidence of surgical complications (adverse events) graded according to Dindo (2004)(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lukas Marti

Leitender Arzt

Cantonal Hospital of St. Gallen

研究点 (1)

Loading locations...

相似试验